Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium
- PMID: 17376508
- PMCID: PMC1963314
- DOI: 10.1016/j.humpath.2006.12.003
Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium
Abstract
Composite rhabdoid tumors are typically adult tumors that contain a component of rhabdoid cells, which are characteristic of the aggressive childhood malignant rhabdoid tumor. Pediatric rhabdoid tumors are characterized by the inactivation of the hSNF5/INI1/SMARCB1 gene, with subsequent loss of expression of the protein. In contrast, only a single composite rhabdoid tumor has demonstrated involvement of the INI1 gene. In our study, INI1 protein expression was studied in 2 uterine carcinosarcomas with rhabdoid components (composite rhabdoid tumors). The rhabdoid component of 1 tumor showed lack of immunoreactivity for the INI1 protein and strong positivity for cyclin D1, whereas the adenocarcinomatous component of the tumor and both components of the second tumor were immunoreactive for the INI1 protein and negative for cyclin D1. Loss of one INI1 allele and a mutation in exon 7 of the remaining allele were detected in the first tumor, consistent with the immunohistochemistry results. Our results demonstrate that deletions and mutations of the INI1 gene can occur also in rare composite rhabdoid tumors of adulthood. Further studies are necessary, however, to determine the prognostic significance of this finding.
Figures




Similar articles
-
INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.Mod Pathol. 2005 Jul;18(7):951-8. doi: 10.1038/modpathol.3800375. Mod Pathol. 2005. PMID: 15761491
-
Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.Clin Cancer Res. 2002 Nov;8(11):3461-7. Clin Cancer Res. 2002. PMID: 12429635
-
Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.Genes Chromosomes Cancer. 2002 May;34(1):33-41. doi: 10.1002/gcc.10052. Genes Chromosomes Cancer. 2002. PMID: 11921280
-
Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Pediatr Hematol Oncol. 2013 Oct;30(7):587-604. doi: 10.3109/08880018.2013.791737. Epub 2013 Jul 12. Pediatr Hematol Oncol. 2013. PMID: 23848359 Review.
-
Atypical teratoid/rhabdoid tumor with ganglioglioma-like differentiation: case report and review of the literature.Hum Pathol. 2014 Jan;45(1):185-8. doi: 10.1016/j.humpath.2013.07.039. Epub 2013 Sep 10. Hum Pathol. 2014. PMID: 24034858 Review.
Cited by
-
Sarcomatoid renal cell carcinoma with rhabdoid features.Ann Saudi Med. 2013 Sep-Oct;33(5):495-9. doi: 10.5144/0256-4947.2013.495. Ann Saudi Med. 2013. PMID: 24188946 Free PMC article.
-
Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.Mod Pathol. 2015 Feb;28(2):248-60. doi: 10.1038/modpathol.2014.100. Epub 2014 Aug 8. Mod Pathol. 2015. PMID: 25103069
-
The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features.Transl Oncol. 2021 Oct;14(10):101175. doi: 10.1016/j.tranon.2021.101175. Epub 2021 Jul 6. Transl Oncol. 2021. PMID: 34243015 Free PMC article.
-
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.Mod Pathol. 2017 Oct;30(10):1422-1432. doi: 10.1038/modpathol.2017.61. Epub 2017 Jun 23. Mod Pathol. 2017. PMID: 28643792
-
Right-sided rhabdoid colorectal tumors might be related to the serrated pathway.Diagn Pathol. 2013 Feb 20;8:31. doi: 10.1186/1746-1596-8-31. Diagn Pathol. 2013. PMID: 23425390 Free PMC article.
References
-
- Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science. 1994;266:1946. - PubMed
-
- Versteege I, Medjkane S, Rouillard D, Delattre O. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Oncogene. 2002;21:6403–12. - PubMed
-
- Medjkane S, Novikov E, Versteege I, Delattre O. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res. 2004;64:3406–13. - PubMed
-
- Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, Wang X, Biegel JA, Pomeroy SL, Mesirov JP, Roberts CW. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci USA. 2005;102:17745–50. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials